This study investigates pancreatic cancer. It focuses on a specific type of imaging called ImmunoPET, which is used to see how a medication spreads in the body.
The purpose of this study is to evaluate the safety and effectiveness of using ImmunoPET imaging to identify how well a treatment might work for pancreatic cancer. It looks at how the imaging can show the distribution of certain proteins in tumors and normal organs.
- Who can participate: Adults with a confirmed or suspected diagnosis of pancreatic cancer may join. Participants must be able to consent and comply with study requirements. Those with allergies to study materials or who are pregnant cannot participate.
- Study details: Participants will undergo special imaging scans to see how a tracer moves in their body. A placebo is not used in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand